Concepedia

Stephanie Zantinge

SZ

Statistics

Publications

4

Citations

143

H-Index

4

Active since

2011

Affiliations

Huntsman Cancer Institute(Current)

Princess Margaret Cancer Centre

National Cancer Institute

The Ohio State University

University of California, Davis

Stephanie Zantinge is an author at Huntsman Cancer Institute specializing in oncology, life sciences, and angioimmunoblastic t cell lymphoma.

Publications per year

2011–2023

4

Publications

4

Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells

Katja Linher‐Melville, Stephanie Zantinge, Toran Sanli et al. · BMC Cancer · 2011 · 74 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

Julio C. Chávez, Francine M. Foss, Basem M. William et al. · Clinical Cancer Research · 2023 · 33 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells

Katja Linher‐Melville, Stephanie Zantinge, Gurmit Singh · Biochemical and Biophysical Research Communications · 2011 · 22 citations

Life Sciences, Molecular Biology, Oncology +12

A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)

Julio C. Chávez, Francine M. Foss, Basem M. William et al. · Blood · 2020 · 14 citations

Pharmacy, Immunology, Oncology +15

1–4 of 4